---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-26-000110"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:51:46.233221+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# GoodRx Q1 revenue $194M, raises FY2026 guidance; Pharma Direct up 82% YoY

## Summary
- Revenue $194.0M; net income $1.2M; adjusted EBITDA $58.3M (30.0% margin).
- Pharma Direct Revenue increased 82% YoY, leading growth momentum.
- Company raises full year 2026 revenue and adjusted EBITDA expectations.
- Adjusted Net Income $23.0M; Adjusted Net Income Margin 11.9%.
- Net cash from operating activities $11.8M.

## SEC filing metadata
- accession: 0001809519-26-000110
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951926000110/0001809519-26-000110-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951926000110/gdrx-20260506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-26-000110
- JSON: https://secwatch.observer/filing/0001809519-26-000110.json
- Plain text: https://secwatch.observer/filing/0001809519-26-000110.txt

## Source-grounded claims
- claim_id: 4c7b09023dcbce24b1aff7e31414aea6c532e8e0
  claim: GoodRx Holdings, Inc. reported first quarter of 2026 results: revenue $194.0 million, net income $1.2 million. Guidance raised.
  evidence_excerpt: the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2026 . First Quarter 2026 Highlights • Revenue of $194.0 million • Net income of $1.2 million ; Net income margin of 0.6% • Adjusted Net Income 1 of $23.0 million ; Adjusted Net Income Margin 1 of 11.9% • Adjusted EBITDA 1 of $58.3 million ;
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000180951926000110/0001809519-26-000110-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.